Drug Testing Misses Synthetic Cannabinoids: Expert

April 14th, 2016

Associate Professor and Director of the Center for Substance Abuse Research (CESAR), Eric Wish, Ph.D. explains that when synthetic cannabinoids were first created, they mimicked the effects of THC, the psychoactive ingredient in marijuana. Currently, the chemical structure of synthetic cannabinoids has changed dramatically resulting in drug tests that are often missing synthetic cannabinoids. This leads to lost opportunities for diagnosis and intervention.

Learn More

Posted in Content

A Project of the Governor's Institute on Alcohol & Substance Abuse and the North Carolina Society of Addiction Medicine.
Funded wholly or in part by the federal Substance Abuse Prevention and Treatment Block Grant Fund (CFDA #93.959) as a project of the NC Division of Mental Health, Developmental Disabilities & Substance Abuse Services.